Dr. Lubomír Janda | Animal model | Best Researcher Award

Principal investigator at Veterinary Research Institute, Czech Republic

Dr. Lubomír Janda, is a renowned molecular biologist with expertise in antibacterial therapy and probiotics. He earned his Ph.D. in Molecular Biology from Charles University in Prague, where he also completed his M.Sc. in Molecular Biology and Genetics. Dr. Janda’s career spans several prestigious institutions, including the University of Vienna and Masaryk University, where he contributed significantly to molecular and microbial research. Currently, he serves as a principal investigator at the Veterinary Research Institute in Brno, leading a team of 10 researchers. With over 38 publications and an H-index of 14, his work addresses critical challenges in healthcare, including antibiotic resistance and celiac disease treatment.

professional profiles

Scopus Profile

Education

Dr. Janda’s academic journey began at Charles University, Prague, where he completed his M.Sc. in Molecular Biology and Genetics in 1989. He advanced to earn a Ph.D. in Molecular Biology in 1998, focusing on the intricate mechanisms of molecular interactions. His education provided a solid foundation in molecular techniques and genetics, which he has leveraged throughout his career. The rigorous training and exposure to cutting-edge research methodologies have equipped him to tackle complex challenges in antimicrobial therapy and probiotics.

work Experience

Dr. Janda’s professional trajectory is marked by significant contributions to molecular biology and applied research. Since 2017, he has been a principal investigator at the Veterinary Research Institute in Brno, leading innovative projects in infectious diseases. Prior to this, he served as a principal investigator at CEITEC, Masaryk University, from 2015 to 2017, and as a senior scientist at the same institution from 2007 to 2014. His international experience includes his tenure as an Assistant Professor at the University of Vienna from 2000 to 2007. Earlier in his career, he worked as a research worker at the Institute of Microbiology, Academy of Sciences, Prague, from 1996 to 1999.

Research Focus

Dr. Janda’s research focuses on two primary areas: antibacterial therapy and probiotics. In antibacterial therapy, he explores innovative solutions such as antimicrobial peptides and enzyme-based treatments to combat multidrug-resistant bacterial strains. His work on probiotics involves studying their role in disease prevention and treatment, particularly in addressing conditions like celiac disease and gut health. His applied research aims to provide sustainable and effective alternatives to traditional antibiotics, making a significant impact on modern medicine.

Conclusion

Dr. Lubomír Janda’s exceptional research contributions, leadership, and focus on solving critical health challenges make him a strong contender for the Best Researcher Award. His work embodies innovation and practical impact, with significant advancements in antibacterial therapy and probiotics. By addressing global challenges like antibiotic resistance and celiac disease, Dr. Janda has demonstrated the transformative power of applied research. While there is room for expanding his interdisciplinary collaborations and public engagement, his achievements to date solidify his reputation as a trailblazer in molecular biology and infectious disease research.

Publications to Noted

Optimizing Tubulin Yield from Porcine Brain Tissue

Authors: Norek, A., Šťastná, M., Gečnuk, J., Gebauer, J., Janda, L.

Citations: 0

Year: 2024

Two Faces of the Antimicrobial Peptides and Their Relevance to Burn Wound Infection

Authors: Váňa, V., Lipový, B., Vacek, L., Janda, L., Holoubek, J.

Citations: 0

Year: 2024

Phage Therapy Combined with Gum Karaya Injectable Hydrogels for Treatment of Methicillin-Resistant Staphylococcus aureus Deep Wound Infection in a Porcine Model

Authors: Vacek, L., Polaštík Kleknerová, D., Lipový, B., Růžička, F., Vojtová, L.

Citations: 1

Year: 2024

A Scoring System for Histological Evaluation of Skin During Staphylococcus aureus Infections

Authors: Makovický, P., Jeklová, E., Lipový, B., Norek, A., Janda, L.

Citations: 2

Year: 2024

Development of a Porcine Model of Skin and Soft-Tissue Infection Caused by Staphylococcus aureus, Including Methicillin-Resistant Strains Suitable for Testing Topical Antimicrobial Agents

Authors: Raška, F., Lipový, B., Kobzová, Š., Faldyna, M., Janda, L.

Citations: 0

Year: 2024

Effect of Enzybiotics on the Healing of Staphylococcus aureus-Infected Skin Wounds in a Pig Model

Authors: Makovický, P., Lipový, B., Jeklová, E., Norek, A., Janda, L.

Citations: 0

Year: 2024

Recombinant Production of Human Antimicrobial Peptide LL-37 and Its Secondary Structure

Authors: Pavelka, A., Vacek, L., Norek, A., Kobzová, Š., Janda, L.

Citations: 2

Year: 2024

Celiac Disease: Promising Biomarkers for Follow-Up

Authors: Hrunka, M., Janda, L., Šťastná, M., Dítě, P., Jabandžiev, P.

Citations: 1

Year: 2023

Antimicrobial Effect of Endolysins LYSDERM-S and LYSDERM-T1 and Endolysin-Ubiquitin Combination on Methicillin-Resistant Staphylococcus aureus

Authors: Vacek, L., Kouřilová, M., Kobzová, Š., Janda, L.

Citations: 2

Year: 2023

Increasing Prevalence of Celiac Disease – Where to Look for Answers?

Authors: Šťastná, M., Norek, A., Řádková, J., Jabandžiev, P., Janda, L.

Citations: 2

Year: 2023

Lubomír Janda | Animal model | Best Researcher Award

Dr. Lubomír Janda | Animal model | Best Researcher Award

professional profiles

Education

work Experience

Conclusion

Publications to Noted

RECOMMENDED

Mail us